New Option for HIV Testing
The FDA recently approved the new VITROS Anti-HIV 1+2 from Ortho Clinical Diagnostics, Raritan, NJ, a diagnostic assay for detecting antibodies to HIV types 1 and/or 2.
Read MorePosted by Clinical Lab Products | May 29, 2008 | Sexually Transmitted Diseases |
The FDA recently approved the new VITROS Anti-HIV 1+2 from Ortho Clinical Diagnostics, Raritan, NJ, a diagnostic assay for detecting antibodies to HIV types 1 and/or 2.
Read MorePosted by Clinical Lab Products | May 1, 2008 | Cancer, Miscellaneous |
Companies look to fill the holes in liver diagnostics.
Read MorePosted by Clinical Lab Products | Apr 13, 2008 | Cancer, Miscellaneous |
American Bio Medica Corp, AviaraDx Inc, Streck Inc, Thermo Fisher Scientific Inc
Read MorePosted by Clinical Lab Products | Apr 2, 2008 | Miscellaneous |
CLP surveys the evolving landscape of point-of-care products.
Read MorePosted by Clinical Lab Products | Mar 31, 2008 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Diazyme Laboratories, Poway, Calif, which develops diagnostic products for clinical and research uses, says the FDA has granted 510(K) clearance for marketing its Enzymatic Total Bile Acids assay kit for the quantitative determination of the acids in human blood samples.
Read More